BioCryst Pharmaceuticals Inc BCRX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
15.68quote price arrow down-0.02 (-0.13%)
Volume
381,786
Close
15.70quote price arrow up+0.49 (+3.22%)
Volume
3,630,327
52 week range
3.30 - 18.48
Loading...
  • Open15.35
  • Day High15.74
  • Day Low15.10
  • Prev Close15.21
  • 52 Week High18.48
  • 52 Week High Date08/06/21
  • 52 Week Low3.30
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap2.808B
  • Shares Out178.87M
  • 10 Day Average Volume2.21M
  • Dividend-
  • Dividend Yield-
  • Beta2.59
  • YTD % Change110.74

KEY STATS

  • Open15.35
  • Day High15.74
  • Day Low15.10
  • Prev Close15.21
  • 52 Week High18.48
  • 52 Week High Date08/06/21
  • 52 Week Low3.30
  • 52 Week Low Date09/24/20
  • Market Cap2.808B
  • Shares Out178.87M
  • 10 Day Average Volume2.21M
  • Dividend-
  • Dividend Yield-
  • Beta2.59
  • YTD % Change110.74

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-12.99
  • Fwd P/E (NTM)-15.56
  • EBITDA (MRQ)-175.504M
  • ROE (MRQ)-1,925.37%
  • Revenue (MRQ)79.14M
  • Gross Margin (MRQ)90.10%
  • Net Margin (MRQ)-270.53%
  • Debt To Equity (MRQ)-276.84%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioCryst Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioCryst Pharmaceuticals, Inc. (BioCryst) is a commercial-stage biotechnology company that discovers small-molecule medicines. The Company focus on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema...
Robert Ingram
Non-Executive Chairman
Jon Stonehouse
Chief Executive Officer
Anthony Doyle
Chief Financial Officer
Address
4505 Emperor Blvd Ste 200
Durham, NC
27703-8457
United States

Top Peers

SYMBOLLASTCHG%CHG
AGIO
Agios Pharmaceuticals Inc
47.14+1.34+2.93%
ITCI
Intra-Cellular Therapies Inc
34.36-0.14-0.41%
RLAY
Relay Therapeutics Inc
37.09+0.09+0.24%
KYMR
Kymera Therapeutics Inc
62.95-1.95-3.00%
NKTR
Nektar Therapeutics
16.51+0.25+1.54%